Liver Biomarkers And Treatments Data

This dataset appears to focus on liver health, metabolic markers, and the effects of different medications. It includes a mix of demographic, clinical, biochemical, and histopathological data points. Below is a detailed breakdown:Demographic Information:Gender: Gender of the individual (e.g., 0 for male, 1 for female or vice versa).Age: Age of the individual in years.Medication Usage:Statin_Usage: Indicates whether statins are being used (0 = no, 1 = yes).Ezetimibe_Usage: Indicates usage of ezetimibe (0 = no, 1 = yes).Fibrate_Usage: Indicates usage of fibrates (0 = no, 1 = yes).EPA_Usage: Indicates usage of EPA (0 = no, 1 = yes).Biochemical Markers:GPT: Levels of glutamate pyruvate transaminase (GPT), a liver enzyme.Gamma-GTP: Levels of gamma-glutamyl transferase (GGT), another liver enzyme.Triglycerides_Serum: Serum triglyceride levels.Lp(a)_mg_dL: Lipoprotein(a) levels measured in mg/dL.Histopathological Findings:Lobular_Inflammation_1, Lobular_Inflammation_2, Lobular_Inflammation_3: Severity levels of lobular inflammation.Ballooning_1, Ballooning_2: Levels of hepatocyte ballooning, indicative of cellular damage.Steatosis_2, Steatosis_3: Levels of steatosis, representing fat accumulation in the liver.Groups and Conditions:Group_Statin+Ezetimibe: Group classification based on combined statin and ezetimibe usage.LiverStage_1, LiverStage_2: Categorical liver disease stages (e.g., 1 for early stage, 2 for advanced stage).